Arctic Bioscience AS (ABS.OL)

NOK 1.9

(-5.0%)

Operating Expenses Summary of Arctic Bioscience AS

  • Arctic Bioscience AS's latest annual operating expenses in 2023 was -5730.00 NOK , down -100.01% from previous year.
  • Arctic Bioscience AS's latest quarterly operating expenses in 2024 Q2 was 14.88 Million NOK , down 0.0% from previous quarter.
  • Arctic Bioscience AS reported a annual operating expenses of 49.03 Million NOK in annual operating expenses 2022, up 7.21% from previous year.
  • Arctic Bioscience AS reported a annual operating expenses of 45.73 Million NOK in annual operating expenses 2021, up 75.76% from previous year.
  • Arctic Bioscience AS reported a quarterly operating expenses of 14.88 Million NOK for 2024 Q1, down -0.92% from previous quarter.
  • Arctic Bioscience AS reported a quarterly operating expenses of 15.02 Million NOK for 2023 Q4, down 0.0% from previous quarter.

Annual Operating Expenses Chart of Arctic Bioscience AS (2023 - 2018)

Historical Annual Operating Expenses of Arctic Bioscience AS (2023 - 2018)

Year Operating Expenses Operating Expenses Growth
2023 -5730.00 NOK -100.01%
2022 49.03 Million NOK 7.21%
2021 45.73 Million NOK 75.76%
2020 26.02 Million NOK 69.89%
2019 15.31 Million NOK 51.63%
2018 10.1 Million NOK 0.0%

Peer Operating Expenses Comparison of Arctic Bioscience AS

Name Operating Expenses Operating Expenses Difference
Aqua Bio Technology ASA 18.46 Million NOK 100.031%
ArcticZymes Technologies ASA 97.26 Million NOK 100.006%
BerGenBio ASA 192.17 Million NOK 100.003%
Hofseth BioCare ASA 156.04 Million NOK 100.004%
PCI Biotech Holding ASA 25.23 Million NOK 100.023%
Thor Medical ASA 7.16 Million NOK 100.08%
Ultimovacs ASA 215.73 Million NOK 100.003%